• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传学和表观遗传学在格雷夫斯眼病中的作用。

Role of genetics and epigenetics in Graves' orbitopathy.

机构信息

Department of Clinical and Experimental Medicine, Endocrinology Units, University of Pisa and University Hospital of Pisa, Pisa, Italy.

Department of Surgical, Medical and Molecular Pathology, Ophthalmopathy Unit I, University of Pisa and University Hospital of Pisa, Pisa, Italy.

出版信息

Eur Thyroid J. 2024 Nov 6;13(6). doi: 10.1530/ETJ-24-0179. Print 2024 Dec 1.

DOI:10.1530/ETJ-24-0179
PMID:39378053
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11623286/
Abstract

OBJECTIVES

The pathogenesis of Graves' orbitopathy (GO) remains to be fully elucidated. Here, we reviewed the role of genetics and epigenetics.

DESIGN

We conducted a PubMed search with the following keywords: GO, thyroid eye disease; or Graves' ophthalmopathy; or thyroid-associated ophthalmopathy; and: genetic, or epigenetic, or gene expression, or gene mutation, or gene variant, or gene polymorphism, or DNA methylation, or DNA acetylation. Articles in which whole DNA and/or RNA sequencing, proteome, and methylome analyses were performed were chosen.

RESULTS

The different prevalence of GO in the two sexes, as well as racial differences, suggest that genetics play a role in GO pathogenesis. In addition, the long-lasting phenotype of GO and patient-derived orbital fibroblasts suggests a genetic or epigenetic mechanism. Although no genes have been found to confer a specific risk for GO, differential gene expression has been reported in orbital fibroblasts from GO patients vs control fibroblasts, suggesting that an epigenetic mechanism may be involved. In this regard, a different degree of DNA methylation, which affects gene expression, has been found between GO and control fibroblasts, which was confirmed by whole methylome analysis. Histone acetylation and deacetylation, which also affect gene expression, remain to be investigated.

CONCLUSIONS

Although no pathogenic gene variants have been reported, epigenetic mechanisms elicited by an initial autoimmune insult seem to be needed for differential gene expression to occur and, thus, for GO to develop and persist over time.

摘要

目的

格雷夫斯眼病(GO)的发病机制仍未完全阐明。在这里,我们回顾了遗传学和表观遗传学的作用。

设计

我们使用以下关键词在 PubMed 上进行了搜索:GO、甲状腺眼病;或格雷夫斯眼病;或甲状腺相关眼病;和:遗传、或表观遗传、或基因表达、或基因突变、或基因变异、或基因多态性、或 DNA 甲基化、或 DNA 乙酰化。选择了进行全 DNA 和/或 RNA 测序、蛋白质组学和甲基组学分析的文章。

结果

GO 在两性中的不同患病率,以及种族差异,表明遗传在 GO 发病机制中起作用。此外,GO 的持久表型和患者来源的眼眶成纤维细胞表明存在遗传或表观遗传机制。尽管尚未发现赋予 GO 特定风险的基因,但已在 GO 患者和对照成纤维细胞的眼眶成纤维细胞中报告了差异基因表达,表明可能涉及表观遗传机制。在这方面,GO 和对照成纤维细胞之间发现了不同程度的 DNA 甲基化,这影响了基因表达,这通过全甲基组分析得到了证实。组蛋白乙酰化和去乙酰化,也影响基因表达,仍有待研究。

结论

尽管尚未报道致病基因变异,但最初的自身免疫攻击引发的表观遗传机制似乎需要发生差异基因表达,从而使 GO 随着时间的推移发展和持续存在。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2224/11623286/59bb5ca46936/ETJ-24-0179fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2224/11623286/e8e6d9aa33fe/ETJ-24-0179fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2224/11623286/59bb5ca46936/ETJ-24-0179fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2224/11623286/e8e6d9aa33fe/ETJ-24-0179fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2224/11623286/59bb5ca46936/ETJ-24-0179fig2.jpg

相似文献

1
Role of genetics and epigenetics in Graves' orbitopathy.遗传学和表观遗传学在格雷夫斯眼病中的作用。
Eur Thyroid J. 2024 Nov 6;13(6). doi: 10.1530/ETJ-24-0179. Print 2024 Dec 1.
2
Genetic Profiling of Orbital Fibroblasts from Patients with Graves' Orbitopathy.Graves 眼病患者眼眶成纤维细胞的基因谱分析。
J Clin Endocrinol Metab. 2021 Apr 23;106(5):e2176-e2190. doi: 10.1210/clinem/dgab035.
3
Integrative Analysis of Proteomics and DNA Methylation in Orbital Fibroblasts From Graves' Ophthalmopathy.Graves 眼病眼眶成纤维细胞蛋白质组学与 DNA 甲基化的综合分析
Front Endocrinol (Lausanne). 2021 Feb 15;11:619989. doi: 10.3389/fendo.2020.619989. eCollection 2020.
4
Emerging Insights Into the Role of Epigenetics and Gut Microbiome in the Pathogenesis of Graves' Ophthalmopathy.探讨表观遗传学和肠道微生物群在格雷夫斯眼病发病机制中的作用的新见解。
Front Endocrinol (Lausanne). 2022 Jan 5;12:788535. doi: 10.3389/fendo.2021.788535. eCollection 2021.
5
A Promising Mouse Model of Graves' Orbitopathy Induced by Adenovirus Expressing Thyrotropin Receptor A Subunit.腺病毒表达促甲状腺激素受体 A 亚基诱导 Graves 眼病的小鼠模型研究
Thyroid. 2021 Apr;31(4):638-648. doi: 10.1089/thy.2020.0088. Epub 2021 Jan 5.
6
Histone Deacetylase 4 Controls Extracellular Matrix Production in Orbital Fibroblasts from Graves' Ophthalmopathy Patients.组蛋白去乙酰化酶 4 控制格雷夫斯眼病患者眼眶成纤维细胞细胞外基质的产生。
Thyroid. 2021 Oct;31(10):1566-1576. doi: 10.1089/thy.2020.0948. Epub 2021 Aug 18.
7
Genetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy.格雷夫斯病的基因谱分析:进一步证明格雷夫斯眼病不存在明显的遗传贡献。
Thyroid. 2012 Jul;22(7):730-6. doi: 10.1089/thy.2012.0007. Epub 2012 Jun 4.
8
Insights Into the Role of DNA Methylation and Gene Expression in Graves Orbitopathy.DNA甲基化和基因表达在格雷夫斯眼病中的作用洞察
J Clin Endocrinol Metab. 2023 Apr 13;108(5):e160-e168. doi: 10.1210/clinem/dgac645.
9
The Role of Fibrogenesis and Extracellular Matrix Proteins in the Pathogenesis of Graves' Ophthalmopathy.纤维生成和细胞外基质蛋白在格雷夫斯眼病发病机制中的作用。
Int J Mol Sci. 2024 Mar 14;25(6):3288. doi: 10.3390/ijms25063288.
10
A genome-wide DNA methylation analysis in peripheral blood from patients identifies risk loci associated with Graves' orbitopathy.一项针对 Graves 眼病患者外周血的全基因组 DNA 甲基化分析确定了与 Graves 眼病相关的风险位点。
J Endocrinol Invest. 2018 Jun;41(6):719-727. doi: 10.1007/s40618-017-0796-6. Epub 2017 Nov 30.

引用本文的文献

1
Oxidative stress-related biomarkers in thyroid eye disease: evidence from bioinformatics analysis and experimental validation.甲状腺眼病中氧化应激相关生物标志物:来自生物信息学分析和实验验证的证据
Front Immunol. 2025 Aug 18;16:1635712. doi: 10.3389/fimmu.2025.1635712. eCollection 2025.

本文引用的文献

1
Gut microbiota as a sensor of autoimmune response and treatment for rheumatoid arthritis.肠道微生物群作为自身免疫反应的传感器及类风湿关节炎的治疗方法。
Immunol Rev. 2024 Aug;325(1):90-106. doi: 10.1111/imr.13359. Epub 2024 Jun 12.
2
Linsitinib, an IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye disease.林西替尼,一种 IGF-1R 抑制剂,可减轻甲状腺眼病模型中的疾病发展和进展。
Front Endocrinol (Lausanne). 2023 Jun 26;14:1211473. doi: 10.3389/fendo.2023.1211473. eCollection 2023.
3
Proof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye Disease.
FcRn 抑制剂巴托昔单抗治疗甲状腺眼病的概念验证和随机、安慰剂对照试验。
J Clin Endocrinol Metab. 2023 Nov 17;108(12):3122-3134. doi: 10.1210/clinem/dgad381.
4
Satralizumab: A Review in Neuromyelitis Optica Spectrum Disorder.satralizumab:视神经脊髓炎谱系疾病的研究进展。
CNS Drugs. 2023 Apr;37(4):363-370. doi: 10.1007/s40263-023-00995-9. Epub 2023 Mar 18.
5
Gut Microbiome Associated With Graves Disease and Graves Orbitopathy: The INDIGO Multicenter European Study.肠道微生物群与格雷夫斯病和格雷夫斯眼病的相关性:INDIGO 多中心欧洲研究。
J Clin Endocrinol Metab. 2023 Jul 14;108(8):2065-2077. doi: 10.1210/clinem/dgad030.
6
Management of Thyroid Eye Disease: A Consensus Statement by the American Thyroid Association and the European Thyroid Association.甲状腺眼病管理:美国甲状腺协会和欧洲甲状腺协会的共识声明。
Thyroid. 2022 Dec;32(12):1439-1470. doi: 10.1089/thy.2022.0251. Epub 2022 Dec 8.
7
Changes of mRNA expression underlying orbital adipogenesis in thyroid-associated orbitopathy.甲状腺相关眼病眶脂肪生成过程中mRNA表达的变化
Arch Med Sci. 2022 Oct 6;18(6):1708-1715. doi: 10.5114/aoms/153478. eCollection 2022.
8
Insights Into the Role of DNA Methylation and Gene Expression in Graves Orbitopathy.DNA甲基化和基因表达在格雷夫斯眼病中的作用洞察
J Clin Endocrinol Metab. 2023 Apr 13;108(5):e160-e168. doi: 10.1210/clinem/dgac645.
9
Single-cell RNA sequencing depicts the local cell landscape in thyroid-associated ophthalmopathy.单细胞 RNA 测序描绘了甲状腺相关眼病中的局部细胞景观。
Cell Rep Med. 2022 Aug 16;3(8):100699. doi: 10.1016/j.xcrm.2022.100699. Epub 2022 Jul 26.
10
Sirolimus as a second-line treatment for Graves' orbitopathy.西罗莫司作为格雷夫斯眼病的二线治疗方法。
J Endocrinol Invest. 2022 Nov;45(11):2171-2180. doi: 10.1007/s40618-022-01862-y. Epub 2022 Jul 13.